Yoshimizu and Kimura (1976) discovered that the composition of salmonid GM changed in salmonids during seawater transfer
A prescription may be issued only when treatment is considered medically appropriate
Aside from hyperhomocysteinemia, C677T or A1298C MTHFR (the two genes most studied) mutations are associated with an increased risk of other conditions including cardiovascular and thromboembolic diseases such as strokes, blood clots, and heart attacks, ADHD in children, pregnancies with neural tube defects, depression, anxiety, diabetic neuropathy, glaucoma migraines, schizophrenia, and colorectal polyps
The data shows that only about 10-15% of participants achieve 15% weight loss through lifestyle changes alone
TL;DR Tirzepatide is a dual GIP/GLP-1 receptor agonist manufactured by Eli Lilly, while semaglutide is a GLP-1 receptor agonist only, made by Novo Nordisk